Enabling Precision MedicineNewomics Inc., a biotechnology company in the San Francisco Bay Area, commercializes innovative (New) and integrative (Omics) platforms and solutions for personalized healthcare.
Our award-winning multinozzle emitter technologies empower mass spectrometry through integration and miniaturization. The microfluidic chip splits incoming flow evenly into multiple smaller streams and hence enhances ionization efficiency significantly to achieve unprecedented robustnessand sensitivity.
Newomics® M3 emitter is the first commercial multinozzle emitter device for mass spectrometry. Our chip is manufactured on silicon using semiconductor microfabrication techniques. The unique chip design with precision-machining method and plug-and-play interface delivers ultimate sensitivity, reliability, simplicity, and ruggedness.
Proprietary platforms and assays enable LC-MS-based proteomics, metabolomics, and lipidomics analyses of small amounts of biological samples, including human plasma and mammalian cells, as well as host cell proteins, CHO cell culture media, and antibody drugs.
May 21, 2018Newomics will globally launch its award-winning plug-and-play M3 emitter at the 66th ASMS Conference on Mass Spectrometry and Allied Topics, June 3-7, 2018, San Diego, CA. Please stop by our Booth #307!
May 20, 2018Newomics will present a scientific poster jointly with Thermo Fisher Scientific at the 66th ASMS Conference on Mass Spectrometry and Allied Topics, June 3-7, 2018, San Diego, CA.
"Sensitivity Improvement for Bottom-Up Proteomics using Silicon Microfluidic Chip-Based Multinozzle Emitter Arrays at Capillary Flow Rates"
Poster ThP 493, 10:30am – 2:30pm, Thursday, June 7th, 2018.
Please come and see how you can achieve nanoflow sensitivity at capillary flow rates!
May 19, 2018Newomics will showcase its award-winning plug-and-play M3 emitter for mass spectrometry at the 2018 BioPacific Conference, June 23, 2018, San Mateo, CA. Please stop by our Booth!